News
AstraZeneca has signed an AI-led research agreement with China's CSPC Pharmaceutical Group worth up to $5.3 billion, which ...
British drugmaker AstraZeneca unveiled on Friday an AI-assisted research partnership with Chinese counterpart CSPC ...
Moolenaar talks to us about artificial intelligence and his ideas for an “America First AI Policy” that would keep the U.S.
That number falls short of Nvidia’s over 1 million China-specific H20 chips produced in the last nine months of 2024, ...
Alexandr Wang dropped out of MIT to co-found Scale and was quickly lauded as one of Silicon Valley's most promising ...
Creating guardrails for AI can't wait, says Jake Sullivan, and the responsibility may ultimately fall on the shoulders of CEOs.
Explore more
Across all industries, roles that ‘collate AI with human expertise’ are in demand and command a premium, report says.
Friday’s deal with fits neatly within AstraZeneca’s business development strategy of upping investments in AI and in China.
The report noted that their responsibilities entail training AI in literary and artistic expression, enhancing the system's ...
From generative AI to autonomous vehicles, European tech startups are breaking new ground — and grappling with the challenges ...
NVIDIA expands across Europe with major AI infrastructure deals, focusing on sovereign AI to offset China losses and boost ...
Former Rep. Chris Stewart argues that the military needs to develop an edge in AI in order to be faster and smarter in the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results